Crossmark

Mesenchymal stem cell therapy for type 2 diabetes: mechanisms, clinical evidence, and future directions

Published Online: 2025-10-21

Published Print: 2025-12

Authors

Zarei, Malek
License Information

Text and Data Mining valid from 2025-10-21

Version of Record valid from 2025-10-21
More Information

Article History

Received: 18 August 2025

Accepted: 2 October 2025

First Online: 21 October 2025

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

: Not applicable.

: Not applicable.

Document is current